ICAM1 and atherosclerosis: Another m6A writer, METTL14, has been shown to interact with FOXO1 and act directly on the promoter regions of VCAM-1 and ICAM-1, which enhanced the binding of monocytes to endothelial cells during atherosclerosis (Jian et al., 2020).